| |
| |
|
| Insider
Information: |
Nanavaty Maulik |
| Relationship: |
|
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,758 |
|
|
Indirect Shares
|
11,017 |
|
|
| Direct
Value |
$13,395,387 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,775 |
|
|
| Total
Value |
$13,395,387 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-05-28 |
4 |
S |
$42.59 |
$3,330,440 |
D/D |
(78,192) |
166,869 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-22 |
4 |
D |
$17.26 |
$219,426 |
D/D |
(12,713) |
167,893 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-23 |
4 |
D |
$17.24 |
$11,930 |
D/D |
(692) |
169,040 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,839 |
169,732 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-24 |
4 |
D |
$17.33 |
$17,434 |
D/D |
(1,006) |
170,710 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-01-01 |
4 |
D |
$42.48 |
$99,658 |
D/D |
(2,346) |
171,406 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,676 |
171,716 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-27 |
4 |
D |
$17.21 |
$18,294 |
D/D |
(1,063) |
172,036 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-15 |
4 |
D |
$44.01 |
$25,306 |
D/D |
(575) |
172,492 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
173,067 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,389 |
173,099 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,175 |
173,752 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-17 |
4 |
D |
$42.83 |
$32,123 |
D/D |
(750) |
173,908 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,166 |
174,658 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-28 |
4 |
D |
$17.21 |
$50,787 |
D/D |
(2,951) |
174,738 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-18 |
4 |
D |
$42.55 |
$26,211 |
D/D |
(616) |
175,071 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,779 |
175,687 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$25,232 |
D/D |
(593) |
176,192 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
176,785 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$24,912 |
D/D |
(564) |
177,258 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,653 |
177,689 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,630 |
177,822 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
33,828 |
180,606 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-01-01 |
4 |
D |
$21.63 |
$117,797 |
D/D |
(5,446) |
184,300 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-02-22 |
4 |
D |
$25.16 |
$17,813 |
D/D |
(708) |
185,474 |
0 |
- |
|
176 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
